How can they possibly still have $5m in cash??? Impossible. That is the figure quoted end of March. According to their website they still have a CEO, a COO and 3 VPs as well as some staff (one would assume) in Germany working in the lab???? People do not come cheap and surely they have spent some cash on trying to resolve the manufacturing issues and in hiring of consultants to give them advice on this issue??
If they have no antibody to run a clinical trial, then they are back to early-stage preclinical assets. How can they develop these assets with little cash and how can they bring in new assets with little cash and a stock price on the floor?
- Forums
- ASX - By Stock
- PAB
- Ann: Manufacturing Update - Clinical Trial Remains on Hold
Ann: Manufacturing Update - Clinical Trial Remains on Hold, page-16
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
-0.001(7.14%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $161 | 24.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 5492487 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1635376 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 5492487 | 0.006 |
13 | 6829276 | 0.005 |
7 | 4425000 | 0.004 |
5 | 2730016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1635376 | 2 |
0.008 | 4991280 | 4 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
0.012 | 552407 | 4 |
Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online